Company news
DIAGNOS inc. news in 2025
DIAGNOS inc.'s news releases, calls and decks from 2025, newest first.
DIAGNOS Appoints Dr. Ismail Ben Ayed as Chief Artificial Intelligence (AI) Scientist to Accelerate our Innovation in Healthcare
December 16, 2025
Diagnos Announces Closing of Oversubscribed $4 Million Brokered Private Placement Led by Centurion One Capital
December 9, 2025
Diagnos Announces Upsize of Previously Announced Brokered Private Placement to $3.65M Led by Centurion One Capital
November 25, 2025
DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on December 5, 2025
November 13, 2025
DIAGNOS Announces $2.0 Million Brokered Private Placement Led by Centurion One Capital
November 10, 2025
DIAGNOS Strengthens Governance and Leadership with the Appointment of Philippe Couillard as Chairman of the Board of Directors
October 30, 2025
DIAGNOS Welcomes Dr. Pierre-Luc Charlebois to its Advisory Board
October 27, 2025
DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on November 9, 2025
October 22, 2025
DIAGNOS to Present at the Centurion One Capital 3rd Annual Bahamas Summit
October 15, 2025
Validated for Global Scale: DIAGNOS Passes Annual MDSAP Audit, Solidifying the Pathway to Approvals with Health Canada & FDA
October 8, 2025
DIAGNOS Announces Voting Results of Meeting of Shareholders
September 25, 2025
DIAGNOS Announces Closing of Private Placement
September 5, 2025
DIAGNOS Announces Private Placement
September 3, 2025
DIAGNOS to Extend Stock Warrants Exercise Period
August 15, 2025
DIAGNOS Announces Extension of Stock Warrants Exercise Period
August 13, 2025
DIAGNOS Files FDA Pre-Submission for its CARA System: Strategic Entry into the U.S. Optometry Market with Support from ORA LLC
July 16, 2025
DIAGNOS Welcomes Veteran Optometrist Dr. Barry A. Ginsberg to its Scientific Advisory Board for the United States
June 25, 2025
DIAGNOS Welcomes Founder of National Vision Associates, Ed Weiner, to its Advisory Board for the United States
June 10, 2025
DIAGNOS Welcomes Former White House Economic Adviser Dr. Tomas J. Philipson to its Advisory Board for the US Market
June 4, 2025
DIAGNOS Announces the Engagement of Allele Capital Partners
May 23, 2025
DIAGNOS Announces Amendment to Convertible Debentures
May 20, 2025
DIAGNOS announces major advances in Cybersecurity certification by the Cyber Defense Operations Center (COCD) for its CARA System application
April 16, 2025
DIAGNOS Provides Additional Information on Amendment to Convertible Debentures
April 14, 2025
DIAGNOS Provides Update on its Health Canada Medical Device Licence Application
April 9, 2025
DIAGNOS Opens First US Office in Florida
March 31, 2025
DIAGNOS is filing for the Saudi FDA Authorization of Its CARA SYSTEM, an AI Assisted Medical Device
March 12, 2025
DIAGNOS to File for FDA Pre-Market Authorization of Its AI-Powered CARA SYSTEM and Engages Ora as Regulatory Specialist
February 25, 2025
DIAGNOS to Present at Centurion One Capital 8th Annual Toronto Growth Conference
February 24, 2025
Correction - Diagnos Announces Closing of Private Placement
February 14, 2025